phthalic acid has been researched along with Dyslipidemias in 3 studies
phthalic acid: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7178
phthalic acid : A benzenedicarboxylic acid cosisting of two carboxy groups at ortho positions.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The goal of this study was to compare the urine levels of bisphenol A and phthalate metabolites in subgroups of patients with metabolic syndrome composed of patients with and without three important components of metabolic syndrome (hypertension, dyslipidemia and diabetes)." | 7.83 | Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study. ( Haluzík, M; Lacinová, Z; Malý, M; Matějková, D; Matoulek, M; Mráz, M; Müllerová, D; Pavloušková, J; Piecha, R; Svačina, Š; Vavrouš, A; Vrbík, K, 2016) |
| " The goal of this study was to compare the urine levels of bisphenol A and phthalate metabolites in subgroups of patients with metabolic syndrome composed of patients with and without three important components of metabolic syndrome (hypertension, dyslipidemia and diabetes)." | 3.83 | Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study. ( Haluzík, M; Lacinová, Z; Malý, M; Matějková, D; Matoulek, M; Mráz, M; Müllerová, D; Pavloušková, J; Piecha, R; Svačina, Š; Vavrouš, A; Vrbík, K, 2016) |
| " In adjusted models, the prevalence and RRs of dyslipidemia increased with tertile group of mono-n-butyl phthalate (MnBP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP), and summed di-(2-ethylhexyl) phthalate (∑DEHP) metabolites with a dose-response relationship in visit 1, as well as persistent dyslipidemia." | 1.72 | Association between urinary phthalate metabolites and dyslipidemia in children: Results from a Chinese cohort study. ( Chen, L; Chen, M; Dong, Y; Gao, D; Li, Y; Ma, J; Ma, Y; Wang, X; Yang, Z; Zou, Z, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, D | 1 |
| Zou, Z | 1 |
| Li, Y | 1 |
| Chen, M | 1 |
| Ma, Y | 1 |
| Chen, L | 1 |
| Wang, X | 1 |
| Yang, Z | 1 |
| Dong, Y | 1 |
| Ma, J | 1 |
| Kim, B | 1 |
| Park, B | 2 |
| Kim, CH | 1 |
| Kim, S | 1 |
| Piecha, R | 1 |
| Svačina, Š | 1 |
| Malý, M | 1 |
| Vrbík, K | 1 |
| Lacinová, Z | 1 |
| Haluzík, M | 1 |
| Pavloušková, J | 1 |
| Vavrouš, A | 1 |
| Matějková, D | 1 |
| Müllerová, D | 1 |
| Mráz, M | 1 |
| Matoulek, M | 1 |
3 other studies available for phthalic acid and Dyslipidemias
| Article | Year |
|---|---|
Association between urinary phthalate metabolites and dyslipidemia in children: Results from a Chinese cohort study.
Topics: Child; Cohort Studies; Dyslipidemias; Environmental Exposure; Environmental Pollutants; Female; Huma | 2022 |
Association between endocrine-disrupting chemical mixture and metabolic indices among children, adolescents, and adults: A population-based study in Korea.
Topics: Adolescent; Adult; Bayes Theorem; Child; Cross-Sectional Studies; Dyslipidemias; Endocrine Disruptor | 2022 |
Urine Levels of Phthalate Metabolites and Bisphenol A in Relation to Main Metabolic Syndrome Components: Dyslipidemia, Hypertension and Type 2 Diabetes. A Pilot Study.
Topics: Benzhydryl Compounds; Biomarkers; Chromatography, High Pressure Liquid; Czech Republic; Diabetes Mel | 2016 |